Cytosorbents (CTSO) Times Interest Earned (2011 - 2026)
Cytosorbents (CTSO) posted Times Interest Earned of -$0.38 for Q1 2026, up 83.66% on a QoQ basis from -$2.33 in Q4 2025, and up 94.67% year-over-year from -$0.2 in Q1 2025.
Cytosorbents (CTSO) Times Interest Earned (2011 - 2026) Analysis & Trends
Cytosorbents' Times Interest Earned history runs 15 years deep, the most recent figure standing at -$0.38 for Q1 2026.
- Quarterly Times Interest Earned rose 94.67% year-over-year to -$0.38 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.74 (up 81.2% YoY) and the FY2025 annual result came in at -$0.28, up 18.13% from the prior year.
- Times Interest Earned was -$0.38 for Q1 2026 at Cytosorbents, up from -$2.33 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.17 in Q2 2025 and bottomed at -$35.7 in Q2 2024.
- A 5-year average of -$8.83 and a median of -$7.56 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned sank 3143.75% — and 2025, when it surged 99.53%.
- Cytosorbents' Times Interest Earned stood at -$2.17 in 2022, then plunged by 621.59% to -$15.63 in 2023, then surged by 51.62% to -$7.56 in 2024, then soared by 69.19% to -$2.33 in 2025, then soared by 83.66% to -$0.38 in 2026.
- Business Quant data shows CTSO's Times Interest Earned at -$0.38 in Q1 2026, -$2.33 in Q4 2025, and -$11.92 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.38 |
| Dec 31, 2025 | -2.33 |
| Sep 30, 2025 | -11.93 |
| Jun 30, 2025 | -0.17 |
| Mar 31, 2025 | -7.14 |
| Dec 31, 2024 | -7.56 |
| Sep 30, 2024 | -2.55 |
| Jun 30, 2024 | -35.70 |
| Mar 31, 2024 | -2.54 |
| Dec 31, 2023 | -15.63 |
| Sep 30, 2023 | -11.61 |
| Jun 30, 2023 | -1.10 |
| Mar 31, 2023 | -12.47 |
| Dec 31, 2022 | -2.17 |
| Sep 30, 2022 | -13.68 |
| Jun 30, 2022 | -12.20 |
| Mar 31, 2022 | -10.93 |
| Dec 31, 2021 | -4.86 |
| Sep 30, 2021 | -0.60 |
| Jun 30, 2021 | -0.73 |